Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 961-970 of 2867 for cancer

Edit search filters
  1. A Study To Evaluate PDS0101 And Pembrolizumab Combination To Treat Subjects With HPV16 + Recurrent And/or Metastatic Head And Neck Squamous Cell Carcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Expanded Access Program With Nivolumab (BMS-936558) In Combination With Ipilimumab (Yervoy®) In Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable Or Metastatic Melanoma (CheckMate 218)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Safety And Efficacy Study Of TX103 CAR-T Cell Therapy For Recurrent Or Progressive Grade 4 Glioma.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate Myeloma-Developing Regimens Using Genomics (MyDRUG)

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. De-Escalated Adjuvant And Definitive Radiation Therapy Informed By DART 2.0 CtHPV-DNA

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Reduced Dose Hypofractionated Radiotherapy For Indolent Non-hodgkin Lymphoma

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  7. A Master Protocol To Evaluate DCC-3009 In Gastrointestinal Stromal Tumor (GIST)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. PKCι & MTOR Inhibition With Auranofin+Sirolimus For Squamous Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. Specialty Compared To Oncology Delivered Palliative Care For Treating Acute Myeloid Leukemia

    Rochester, MN

  10. A Study To Evaluate The Safety, Tolerance And Anti-tumor Activity Of SAR442257 In Patients With Relapsed/Refractory Multiple Myeloma And Relapsed/Refractory Non-Hodgkin Lymphoma

    Rochester, MN

.

Mayo Clinic Footer